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Application of proteins and peptides as human therapeutics is 
expanding rapidly as drug discovery molecules emerge from -
omics research programmes. Accompanying the discovery of 
novel peptides and proteins a better understanding of the 
mechanism of action in vivo is emerging.1,2 
Unfortunately, many peptide-based molecules have properties 
that are not always conducive to oral delivery and therefore must 
be injected at great cost and inconvenience to patients. The oral 
route of administration of these substances remains unavailable 
because they are generally destroyed by the digestive system, 
while injected proteins can be removed from the body by 
proteolytic digestion or rapid renal excretion.2 Many biological 
proprieties of polypeptides-based drugs, such as plasma half-lives, 
stability, and therapeutic potency can be substantially improved 
by reaction of the latter with appropriate chain-end functionalized 
poly(ethylene glycol) (PEG), “pegylation”.1-5 In some cases, the 
PEG chains can also be predictably detached in vivo from the 
conjugate, introducing the benefits of controlled release of native 
protein therapeutics.6 α-Aldehyde-terminally functional 
polyethylene glycol have been termed “second generation” 
pegylation agents. This class of derivatives has been developed in 
order to circumvent problems often related to pegylation 
chemistry, such as low purity of the reagents, side reactions and 
poor selectivity in substitution can lead to single site attachment 
at the terminal amine under appropriate reaction conditions.1  
 
Scheme 1. Conjugation of α-aldehyde-functional polymer with proteins  
Conjugation reactions occur via a reductive amination 
pathway, in which an imino linkage is formed prior to reduction 
in situ to a stable secondary amine with basicity comparable to 
that of the parent primary amine (Scheme 1).7 This a very 
important parameter, especially when the amino positive charge is  
 
 
Scheme 2. Multi-site conjugation of polymer and lysozyme 
critical for the retention of biological activity.4,8  
Although the chemistry of peptide-polymer conjugation has 
been widely developed, few examples of use of polymers other 
than PEG have been reported thus far.9,10 In this present work we 
have explored the use of new α-aldehyde-functional 
poly(methoxyPEG)methacrylates obtained via Cu(I) mediated 
living radical polymerization and application of these materials in 
conjugation reactions with a model protein, lysozyme (Scheme 
2).11 It is noted that graft polymers of 
poly(methoxyPEG)methacrylates have been previously 
investigated as components of oral drug delivery copolymers. 12 
Living radical polymerization (LRP) is a route to polymer 
architectures unavailable by other synthetic techniques, allowing 
many functional monomers to be incorporated into 
macromolecules with designed architecture and function.13 The 
possibility to obtain polymers with a narrow molecular weight 
distribution is also a crucial parameter as polydisperse polymers 
reflect in polydispersity of the target polypeptide-polymer 
conjugate.4 An acetal initiator has been previously used for living 
anionic ring opening polymerization of ethylene oxide to give 
aldehyde functional polymers 14; it is noted that living radical 
polymerization is extremely diverse in the number of potential 
monomers in addition to being robust towards protic groups in the 
system. 13 Our synthetic strategy is summarized in Scheme 3. In 
the first step an α-functional polymer was obtained with LRP 
using methoxyPEG(1100)methacrylate monomer and initiator 2. 
Subsequently the resulting polymer was conjugated with 
lysozyme.  
 
Scheme 3. Reagents and conditions: (a) Ethylene glycol, KOH, 115 ºC 
(b) 2-bromo isobutyryl bromide, Et3N, 0 ºC; (c) Cu(I)X (X=Cl, Br)/N-
(Ethyl)-2 pyridylmethanimine, methoxyPEG(1100)methacrylate, toluene; 
T = 80 ºC (X = Cl) or T = 50 ºC (X = Br), (d) CF3COOH/H2O 1:1, rt. 
Initiator 2 was obtained by treatment of the commercially 
available 2-chloro-1,1-dimethoxy-ethane with ethylene glycol 
under basic conditions, followed by acylation with 2-bromo 
isobutyryl bromide. Polymerization of (PEG1100-methyl 
ether)methacrylate in the presence of Cu(I)Cl and an 
iminopyridine ligand 15 furnished the intermediate 3a. The 
product was isolated from the relatively high mass monomer 
(1100 g mol-1) by ultrafiltration and subsequent freeze-drying. 
The polymer was subsequently deprotected with TFA/water to 
give the α-aldehyde-terminally functional polymer 4a. The 
reaction was monitored by 1H NMR with H1 and H2 visible at 
3.38 and 9.72 ppm respectively (Scheme 3). The molecular 
weight distribution of the polymer before (Mn = 11 000, PDi = 
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 1.14) and following end group hydrolysis (Mn = 11 000, PDi = 
1.16) confirmed that no backbone hydrolysis occurred during this 
deprotection. Two further α-aldehyde-terminally functional 
polymers were synthesized with Mn = 22 000 (PDi = 1.09), 3b/4b 
and 32 000 (PDi = 1.11) g mol-1 3c/4c respectively. In these 
reactions Cu(I)Br was used in place of Cu(I)Cl resulting in a 
faster polymerisation with the reaction temperature set higher 
accordingly (see supplementary information). In all of the 
polymerization reactions the kinetics showed a linear dependence 
with respect to the monomer concentration and the polymers all 
had a narrow molecular weight distribution (PDI ranging from 
1.09 to 1.15), consistent with living polymerisation. Thus this 
approach enables the synthesis of α-aldehyde-terminally 
functional polymers with predictable Mn and narrow PDi. 
The polymers were screened for their reactivity towards protein 
conjugation with lysozyme as a model substrate. Conjugation 
reactions were carried out at pH 5 and 6 using an excess of 
polymer with NaCNBH3 as an in situ reducing agent. The 
reactions were followed by size-exclusion (SEC)-HPLC and 
showed a similar trend for all of the three polymers, with the 
signal from free lysozyme decreasing with time and a new peak 
corresponding to the conjugates increasing (Figure 1). It is noted 
that the free polymer gives only a weak signal at λ = 225 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. SEC-HPLC analysis of the reaction mixture obtained in the 
conjugation reaction of polymer 4a with lysozyme. 
Conjugation occurred faster at pH 5 that at pH 6 ascribed to the 
fact that at lower pH the formation of the imino linkage between 
the polymer and the protein may be favored. SDS-PAGE analysis 
of the conjugates confirmed the disappearance of the lysozyme 
starting material and the appearance of high molecular weight 
conjugates16 (Figure 2). Lysozyme has seven free amino groups 
from lysine residues and the terminal group with the 
electrophoresis indicating multi site attachment.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. SDS-PAGE for the conjugation of lysozyme with 4a. (A) 
Protein standards, (B) Lysozyme, (C) Protein – polymer bioconjugate 
(reaction at pH 5), Protein – polymer bioconjugate (reaction at pH 6). 
This makes it an ideal candidate as a model protein, however, it is 
noted that pegylation with even a single 12 kDa linear polymer 
has been previously shown to eliminate lysozyme activity. 6b  
 
In summary, we have described the synthesis of new α-
aldehyde-terminated poly(methoxyPEG)methacrylates obtained 
via Cu(I) mediated living radical polymerization, and their 
application for the conjugation of proteins using lysozyme as a 
model. Living radical polymerization with a functional initiator 
leads to pure monofunctionalized products with absence of 
difunctional impurities which can lead to unwanted proteins 
cross-linking. This method appears to be very general and may be 
extended to many proteins and most of the monomers amenable to 
metal-catalyzed living radical polymerization. Future work will 
focus on investigation of proteins where biological activity is 
expected to be retained following conjugation. 
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ABSTRACT FOR WEB PUBLICATION (Word Style 
“BD_Abstract”). Authors are required to submit a concise, 
self-contained, one-paragraph abstract for Web publication. 
Application of proteins and peptides as human therapeutics 
is expanding rapidly as drug discovery become more 
prevalent. Conjugation of polymers to proteins can 
circumvent many problems and pegylation of proteins is 
now emerging as acceptable practice.  This paper  
describes the synthesis of α-aldehyde-terminated 
poly(methoxyPEG)methacrylates from Cu(I) mediated living 
radical polymerization (Mn = 11 000, 22 000 and 32 000; 
PDi < 1.15), and their efficient conjugation to lysozyme, as 
a model protein. This offers an attractive and flexible 
alternative to linear poly(ethylene glycol) opening up the 
possibility of using the full power of living radical 
polymerization. 
 
